Table 1.
Clinical characteristics of patients included in the study
| Characteristic | Patients N = 42a |
|---|---|
| Sex, n (%) | |
| Male | 27 (64.3) |
| Female | 15 (35.7) |
| BMI, kg/m2, mean (SD) | 27.1 (± 4.5) |
| Any smoking, n (%) | |
| Never | 22 (52.4) |
| Yes | 19 (45.2) |
| Comorbidity, n (%) | |
| Hypertension | 28 (66.7) |
| Dyslipidemia | 21 (50.0) |
| Diabetes | 11 (26.2) |
| Psoriatic arthritis | 10 (23.8) |
| Psychiatric disease | 7 (16.7) |
| Thyroiditis | 7 (16.7) |
| Atopy/allergies | 4 (9.5) |
| Chronic obstructive pulmonary disease | 4 (9.5) |
| Cardiovascular disease | 3 (7.1) |
| Neurologic disease | 1 (2.4) |
| Psoriasis characteristics | |
| Age at psoriasis diagnosis, mean ± SD | 40.4 ± 12.9 |
| No. of previous therapies, mean ± SD | 3.8 ± 1.9 |
| Biological therapies, n (%) | |
| Bio-naive | 12 (28.6) |
| Bio-experienced | 30 (71.4) |
| PASI, mean ± SD | 17.2 ± 6.0 |
| DLQI, mean ± SD | 19.5 ± 5.7 |
| VAS pain, mean ± SD | 2.7 ± 3.6 |
| VAS itch, mean ± SD | 6.1 ± 3.3 |
BMI body mass index, PASI Psoriasis Area and Severity Index, DLQI Dermatology Life Quality Index, VAS visual analogue scale
aNumbers do not always add up to the total due to missing data